{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:55:31Z","timestamp":1771001731959,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2005,10,20]],"date-time":"2005-10-20T00:00:00Z","timestamp":1129766400000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\n\t\t\t\t\t<\/jats:bold> Racemic \u03b2<jats:sub>2<\/jats:sub>\u2010adrenergic receptor agonists (\u03b2<jats:sub>2<\/jats:sub>\u2010agonists) are used frequently to treat patients with asthma. Potential differences in the biological activities and clinical efficacies among racemic \u03b2<jats:sub>2<\/jats:sub>\u2010agonists and their isomers are controversial, and research into these possible differences is limited.<\/jats:p><jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> We hypothesized that the (<jats:italic>S<\/jats:italic>)\u2010 and the (<jats:italic>R<\/jats:italic>)\u2010isomers of \u03b2<jats:sub>2<\/jats:sub>\u2010agonists have opposing effects on the activation of inflammatory cells.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> Isolated human eosinophils were pretreated with 1\u2003:\u20031 racemic (<jats:italic>R<\/jats:italic>,<jats:italic>S<\/jats:italic>)\u2010, (<jats:italic>R<\/jats:italic>)\u2010 or (<jats:italic>S<\/jats:italic>)\u2010albuterol, isobutyl methylxanthine (IBMX), and stimulated with IL\u20105. The kinetics of superoxide production were examined by reduction of cytochrome <jats:italic>c<\/jats:italic>, and the effects of pharmacological agents on superoxide production were monitored for 180\u2003min.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> (<jats:italic>R<\/jats:italic>,<jats:italic>S<\/jats:italic>)\u2010albuterol inhibited IL\u20105\u2010induced superoxide production. This inhibition was enhanced by a cyclic adenosine monophosphate (cAMP) phosphodiesterase inhibitor, IBMX, and was reversed by the selective \u03b2<jats:sub>2<\/jats:sub>\u2010adrenergic receptor antagonist, ICI 118,\u2003551, verifying the involvement of both cAMP and the \u03b2<jats:sub>2<\/jats:sub>\u2010adrenergic receptor. In addition, (<jats:italic>R<\/jats:italic>)\u2010albuterol alone, similarly to (<jats:italic>R<\/jats:italic>,<jats:italic>S<\/jats:italic>)\u2010albuterol, significantly inhibited IL\u20105\u2010induced superoxide production up to 60\u2003min (<jats:italic>P<\/jats:italic>&lt;0.05, <jats:italic>n<\/jats:italic>=4), but the inhibition was lost with longer incubation. In contrast, (<jats:italic>S<\/jats:italic>)\u2010albuterol with IBMX did not inhibit IL\u20105\u2010induced superoxide production before 60\u2003min, but it significantly enhanced IL\u20105\u2010mediated superoxide production after 60\u2003min (<jats:italic>P<\/jats:italic>&lt;0.05, <jats:italic>n<\/jats:italic>=4). When both were present as racemic (<jats:italic>R<\/jats:italic>,<jats:italic>S<\/jats:italic>)\u2010albuterol, the inhibitory effect of (<jats:italic>R<\/jats:italic>)\u2010albuterol was not affected by (<jats:italic>S<\/jats:italic>)\u2010albuterol.<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> When incubated with IL\u20105\u2010activated eosinophils, (<jats:italic>R<\/jats:italic>)\u2010albuterol shows anti\u2010inflammatory effects and (<jats:italic>S<\/jats:italic>)\u2010albuterol shows pro\u2010inflammatory effects in the presence of IBMX. The kinetics of these effects are different, and when used simultaneously, (<jats:italic>R<\/jats:italic>)\u2010albuterol predominates. When marked usage of the (<jats:italic>S<\/jats:italic>)\u2010isomer is anticipated, racemic (<jats:italic>R<\/jats:italic>,<jats:italic>S<\/jats:italic>)\u2010albuterol should be used clinically with caution.<\/jats:p>","DOI":"10.1111\/j.1365-2222.2005.02347.x","type":"journal-article","created":{"date-parts":[[2005,10,20]],"date-time":"2005-10-20T19:13:29Z","timestamp":1129835609000},"page":"1341-1346","source":"Crossref","is-referenced-by-count":22,"title":["Effects of (<i>R<\/i>)\u2010 and (<i>S<\/i>)\u2010isomers of \u03b2\u2010adrenergic agonists on eosinophil response to interleukin\u20105"],"prefix":"10.1111","volume":"35","author":[{"given":"G. W.","family":"Volcheck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kelkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. R.","family":"Bartemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. J.","family":"Gleich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,10,20]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"35","article-title":"Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium","volume":"42","author":"Frigas E","year":"1980","journal-title":"Lab Invest"},{"key":"e_1_2_6_3_2","first-page":"345","article-title":"Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma","volume":"56","author":"Frigas E","year":"1981","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.105712"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201303260504"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830200632"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03496-6"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200208-789OC"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202203260801"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)93098-A"},{"key":"e_1_2_6_11_2","first-page":"1426","article-title":"Bronchodilator treatment in moderate asthma or chronic bronchitis","volume":"303","author":"Schayck CP","year":"1991","journal-title":"continuous or on demand? A randomised controlled study"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92695-P"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199210223271704"},{"key":"e_1_2_6_14_2","first-page":"47","article-title":"Salbutamol\u2010induced increased airway responsiveness to allergen and reduced protection versus methacholine","volume":"97","author":"Bhagat R","year":"1996","journal-title":"dose response"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.10027"},{"key":"e_1_2_6_16_2","first-page":"449","article-title":"Modulation of T\u2010cell function by (R)\u2010 and (S)\u2010isomers of albuterol","volume":"109","author":"Baramki D","year":"2002","journal-title":"anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/pupt.1997.0082"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(91)90315-7"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(89)90125-5"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.4049\/jimmunol.146.8.2712","article-title":"Regulation of Ig\u2010induced eosinophil degranulation by adenosine 3\u2032,5\u2032\u2010cyclic monophosphate","volume":"146","author":"Kita H","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_6_21_2","first-page":"597","article-title":"Effects of xanthine derivatives on lipolysis and on adenosine 3\u2032,5\u2032\u2010monophosphate phosphodiesterase activity","volume":"6","author":"Beavo JA","year":"1970","journal-title":"Mol Pharmacol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1992.tb03081.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000235483"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1998.00263.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02772201"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/36362"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.53.3.347"},{"key":"e_1_2_6_28_2","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.4049\/jimmunol.147.6.1905","article-title":"Mechanisms of granule enzyme secretion from permeabilized guinea pig eosinophils. Dependence on Ca2+ and guanine nucleotides","volume":"147","author":"Cromwell O","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1998.275.3.C623"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70332-X"},{"key":"e_1_2_6_31_2","first-page":"128","article-title":"Levalbuterol compared to racemic albuterol","volume":"123","author":"Truitt T","year":"2003","journal-title":"efficacy and outcomes in patients hospitalized with COPD and asthma"},{"key":"e_1_2_6_32_2","first-page":"S10","article-title":"Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma [abstract]","volume":"38","author":"Schreck DM","year":"2001","journal-title":"Ann Emerg Med"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.1999.13f04.x"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.2005.02347.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.2005.02347.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:16:36Z","timestamp":1697174196000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.2005.02347.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1365-2222.2005.02347.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.2005.02347.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}